In the ever-evolving world of medical technology, leadership transitions often mark pivotal moments—not just for shareholders or employees, but for the trajectory of innovation itself. This summer, all eyes are on Baxter International as it prepares for one of its most significant executive shake-ups in recent memory. With the appointment of Andrew Hider as the company’s incoming Chief Executive Officer, the global healthcare community is watching closely. After years of industry consolidation, competitive pressures, and shifting regulatory demands, Baxter appears poised for a new era of direction and purpose 🌐. Based in Deerfield, Illinois, Baxter has long held a prominent position in the global medtech sector, manufacturing a wide range of products from dialysis machines to intravenous solutions. But the appointment of a CEO from outside traditional healthcare—a seasoned leader in industrial automation—raises eyebrows and questions. Why now? Why Andrew Hider? And what does thi...